Source: PR Newswire

Press Release: Brand Institute : Brand Institute Partners on Brand Name Development for FDA-Approved Nasal Spray to Reverse Fentanyl and Other Opioid Overdoses

MIAMI, May 30, 2023 /PRNewswire/ -- Brand Institute is proud to announce its work in developing the brand name Opvee (nalmefene) Nasal Spray from Indivior (through its wholly owned subsidiary, Opiant Pharmaceuticals, Inc.), which was approved by the U.S. Food and Drug Administration...

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
250-500
James L. Dettore's photo - Founder & CEO of Brand Institute

Founder & CEO

James L. Dettore

CEO Approval Rating

90/100

Read more